Gland Pharma Limited is a globally recognized pharmaceutical company specializing in sterile injectables, contract development and manufacturing (CDMO), and complex injectable formulations. Established in 1978, the company has evolved into one of the world’s leading manufacturers of injectable pharmaceuticals, serving customers across more than 60 countries. Gland Pharma develops and manufactures generic injectables, oncology products, ophthalmic solutions, and lyophilized formulations for hospitals and healthcare providers worldwide. The company has built strong relationships with multinational pharmaceutical companies through its expertise in contract manufacturing and regulatory compliance. Its advanced manufacturing facilities are approved by leading regulatory authorities, including the US FDA, EMA, MHRA, and other international agencies. By investing in automation, quality systems, and research and development, Gland Pharma continues to expand its portfolio of complex injectable products. The company’s commitment to quality, operational excellence, and innovation has positioned it as one of India’s leading injectable pharmaceutical manufacturers.
NSE: GLAND | BSE: 543245
Hyderabad, Telangana, India
~8,500 employees
